Skip to content

Dokter Marilou Vandepitte

Active Private limited companyfounded 2024active for 2 yearsSint-Niklaasstraat 1A, 8900 YpresKBO/BCE: BE 1015.512.794

Lifetime

2 annual accounts with figures on one time axis
peak of €111,823 in 2025
€111,823▲ 999%
peak of €87,270 in 2025
€87,270▲ 11×
peak of €96,147 in 2025
€96,147▲ 914%
€15,593▲ 96.9%
Board1 name since 2024
1 director
Documentsfilings and deeds
28-08-202628 days late
2025micro format
Gross margin from €10,175 to €111,823Result from €7,911 to €87,270Dividend €600Equity from €9,478 to €96,147Debts from €7,919 to €15,593Cash from €12,774 to €74,447

Key points

from the 2025 annual accounts

Equity

€96,147 ▲ 914%
9,4782024+87,270Profit-600Dividend96,1472025

Dokter Marilou Vandepitte paid out €600 in dividends. That is 1% of the 2025 profit.

Result

€87,270 ▲ 11×
€7,9102024€87,3002025

The result rose in 2025 from €7,911 to €87,270.

Liquidity

8.37 was 4.39 in 2024

Short-term debts rose from €3,484 to €13,042.

2025 accounts filed 28 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,327 companies had the same profile as Dokter Marilou Vandepitte has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,327 companies, not a prediction for Dokter Marilou Vandepitte. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 24-10-2024
  • founderdeed of 28-10-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1015512794
Incorporation Founded by · 100 shares · appointed as director · published on 28-10-2024 · Gazette deed
First establishment Ypermanstraat 4, Ypres
All 5 events

Comparable companies

same main activity, similar in size and age
Company
Dokter Marilou Vandepitte Ypres €111,740 €111,823 86.0% -
AegiMed Westerlo €106,262 €107,275 76.6% -
Dr MARTIAL Blegny €127,307 €107,922 65.1% -
Dr. Pauline Van den Bossche Waasmunster €128,700 €112,845 68.7% -
DR. AN VERSMISSEN Duffel €113,837 €101,766 84.8% -
Dr. Brian Curtis Lummen €128,758 €115,274 80.7% -
MG MED Anderlecht €121,753 €106,500 71.4% -

These companies have the same main activity as Dokter Marilou Vandepitte: general medical practice (NACE 86210). They are comparable in size and age: total assets between €106,000 and €129,000, founded between 2024 and 2025.

Official details

Source: KBO
Status
Active since 24-10-2024Normal situation
Activity
General medical practiceNACE 86210and 1 other
Establishment unit
2.366.252.7418900 Ypres, since 24-10-2024
Financial year end
31 December
Peppol
Reachable since 20-05-2026
Company details

Annual accounts 2025

≈ €200,000estimated
€111,740▲ 542%
Filing
Filed on 28-08-2026
Financials

Insights on Dokter Marilou Vandepitte

Dokter Marilou Vandepitte has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €96,147 and a net result of €87,270.

Its solvency ranks better than 78% of 21,385 sector peers (NACE 86) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dokter Marilou Vandepitte

What is the company number of Dokter Marilou Vandepitte?
The company number of Dokter Marilou Vandepitte is 1015.512.794. The VAT number is the same number with BE in front: BE 1015.512.794.
Where is Dokter Marilou Vandepitte based?
The registered office is at Sint-Niklaasstraat 1A, 8900 Ypres.Company details
What does Dokter Marilou Vandepitte do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dokter Marilou Vandepitte?
Dokter Marilou Vandepitte is a private limited company (BV).
When was Dokter Marilou Vandepitte founded?
Dokter Marilou Vandepitte was founded on 24-10-2024.
Is Dokter Marilou Vandepitte still active?
Yes, Dokter Marilou Vandepitte is an active enterprise in the KBO register.
What is the turnover of Dokter Marilou Vandepitte?
The turnover in financial year 2025 is about €200,000. This figure is estimated from the gross margin of €111,823 and 30 comparable companies (NACE 86210). It probably lies between €160,000 and €250,000.Financials
Is Dokter Marilou Vandepitte profitable?
In financial year 2025, Dokter Marilou Vandepitte made a profit of €87,270.
Where can I find the annual accounts of Dokter Marilou Vandepitte?
Dokter Marilou Vandepitte filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dokter Marilou Vandepitte due?
Dokter Marilou Vandepitte must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.